SEC INSIDER TRANSACTIONS

GILEAD SCIENCES, INC. (GILD) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

GILD · GILEAD SCIENCES, INC.

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 34 filings · fetched 2026-11-13T18:00:06Z

Recent reported activity

0purchase rows on this page

10sale rows on this page

110matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-08-26Filed 2026-08-27	WELTERS ANTHONYDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. F2 Sale prices for the transactions reported range from $147.58 to $148.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $148.58 to $149.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $147.57 to $148.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 Sale prices for the transactions reported range from $148.57 to $149.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F6 100% of the shares subject to the stock option vested immediately upon the grant date of October 22, 2020. F7 25% of the shares subject to the option vested on each three-month anniversary measured from October 22, 2020 such that 100% of the shares subject to the option were fully vested and exercisable on October 22, 2021. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	3,118D	148.3106	Direct	Form 4 ↗0001213307-26-000005
2026-08-26Filed 2026-08-27	WELTERS ANTHONYDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. F2 Sale prices for the transactions reported range from $147.58 to $148.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $148.58 to $149.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $147.57 to $148.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 Sale prices for the transactions reported range from $148.57 to $149.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F6 100% of the shares subject to the stock option vested immediately upon the grant date of October 22, 2020. F7 25% of the shares subject to the option vested on each three-month anniversary measured from October 22, 2020 such that 100% of the shares subject to the option were fully vested and exercisable on October 22, 2021. References: F1	M Exercise / conversionCommon Stock · Non-derivative	7,718A	60.67	Direct	Form 4 ↗0001213307-26-000005
2026-08-20Filed 2026-08-21	Bluestone JeffreyDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. F2 Sale prices for the transactions reported range from $143.31 to $144.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $144.32 to $145.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $145.34 to $146.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 25% of the shares subject to the option vested on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option are fully vested. F6 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022. References: F1, F6	M Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative	335D	0	Direct	Form 4 ↗0001771814-26-000005
2026-08-20Filed 2026-08-21	Bluestone JeffreyDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. F2 Sale prices for the transactions reported range from $143.31 to $144.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $144.32 to $145.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $145.34 to $146.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 25% of the shares subject to the option vested on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option are fully vested. F6 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022. References: F1, F5	M Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative	4,665D	0	Direct	Form 4 ↗0001771814-26-000005
2026-08-20Filed 2026-08-21	Bluestone JeffreyDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. F2 Sale prices for the transactions reported range from $143.31 to $144.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $144.32 to $145.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $145.34 to $146.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 25% of the shares subject to the option vested on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option are fully vested. F6 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022. References: F1	S Sale (market/private)Common Stock · Non-derivative	335D	146.26	Direct	Form 4 ↗0001771814-26-000005
2026-08-20Filed 2026-08-21	Bluestone JeffreyDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. F2 Sale prices for the transactions reported range from $143.31 to $144.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $144.32 to $145.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $145.34 to $146.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 25% of the shares subject to the option vested on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option are fully vested. F6 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022. References: F1	M Exercise / conversionCommon Stock · Non-derivative	335A	61.35	Direct	Form 4 ↗0001771814-26-000005
2026-08-20Filed 2026-08-21	Bluestone JeffreyDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. F2 Sale prices for the transactions reported range from $143.31 to $144.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $144.32 to $145.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $145.34 to $146.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 25% of the shares subject to the option vested on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option are fully vested. F6 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022. References: F1	S Sale (market/private)Common Stock · Non-derivative	26D	146.36	Direct	Form 4 ↗0001771814-26-000005
2026-08-20Filed 2026-08-21	Bluestone JeffreyDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. F2 Sale prices for the transactions reported range from $143.31 to $144.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $144.32 to $145.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $145.34 to $146.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 25% of the shares subject to the option vested on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option are fully vested. F6 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022. References: F1	M Exercise / conversionCommon Stock · Non-derivative	26A	67.45	Direct	Form 4 ↗0001771814-26-000005
2026-08-20Filed 2026-08-21	Bluestone JeffreyDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. F2 Sale prices for the transactions reported range from $143.31 to $144.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $144.32 to $145.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $145.34 to $146.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 25% of the shares subject to the option vested on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option are fully vested. F6 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022. References: F1, F4	S Sale (market/private)Common Stock · Non-derivative	1,658D	145.7286	Direct	Form 4 ↗0001771814-26-000005
2026-08-20Filed 2026-08-21	Bluestone JeffreyDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. F2 Sale prices for the transactions reported range from $143.31 to $144.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $144.32 to $145.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $145.34 to $146.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 25% of the shares subject to the option vested on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option are fully vested. F6 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022. References: F1	M Exercise / conversionCommon Stock · Non-derivative	1,658A	67.45	Direct	Form 4 ↗0001771814-26-000005
2026-08-20Filed 2026-08-21	Bluestone JeffreyDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. F2 Sale prices for the transactions reported range from $143.31 to $144.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $144.32 to $145.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $145.34 to $146.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 25% of the shares subject to the option vested on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option are fully vested. F6 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022. References: F1, F3	S Sale (market/private)Common Stock · Non-derivative	1,816D	144.9248	Direct	Form 4 ↗0001771814-26-000005
2026-08-20Filed 2026-08-21	Bluestone JeffreyDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. F2 Sale prices for the transactions reported range from $143.31 to $144.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $144.32 to $145.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $145.34 to $146.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 25% of the shares subject to the option vested on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option are fully vested. F6 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022. References: F1	M Exercise / conversionCommon Stock · Non-derivative	1,816A	67.45	Direct	Form 4 ↗0001771814-26-000005
2026-08-20Filed 2026-08-21	Bluestone JeffreyDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. F2 Sale prices for the transactions reported range from $143.31 to $144.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $144.32 to $145.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $145.34 to $146.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 25% of the shares subject to the option vested on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option are fully vested. F6 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	1,165D	143.7543	Direct	Form 4 ↗0001771814-26-000005
2026-08-20Filed 2026-08-21	Bluestone JeffreyDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. F2 Sale prices for the transactions reported range from $143.31 to $144.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $144.32 to $145.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $145.34 to $146.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 25% of the shares subject to the option vested on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option are fully vested. F6 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022. References: F1	M Exercise / conversionCommon Stock · Non-derivative	1,165A	67.45	Direct	Form 4 ↗0001771814-26-000005
2026-08-17Filed 2026-08-18	Mercier JohannaOfficer · Chief Comm & Corp Aff Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. F2 Sale prices for the transactions reported range from $136.74 to $137.73. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $137.75 to $138.36. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1, F4	M Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative	1,890D	0	Direct	Form 4 ↗0001782135-26-000028
2026-08-17Filed 2026-08-18	Mercier JohannaOfficer · Chief Comm & Corp Aff Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. F2 Sale prices for the transactions reported range from $136.74 to $137.73. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $137.75 to $138.36. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1, F4	M Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative	23,110D	0	Direct	Form 4 ↗0001782135-26-000028
2026-08-17Filed 2026-08-18	Mercier JohannaOfficer · Chief Comm & Corp Aff Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. F2 Sale prices for the transactions reported range from $136.74 to $137.73. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $137.75 to $138.36. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1, F3	S Sale (market/private)Common Stock · Non-derivative	11,470D	138.0353	Direct	Form 4 ↗0001782135-26-000028
2026-08-17Filed 2026-08-18	Mercier JohannaOfficer · Chief Comm & Corp Aff Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. F2 Sale prices for the transactions reported range from $136.74 to $137.73. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $137.75 to $138.36. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	16,530D	137.365	Direct	Form 4 ↗0001782135-26-000028
2026-08-17Filed 2026-08-18	Mercier JohannaOfficer · Chief Comm & Corp Aff Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. F2 Sale prices for the transactions reported range from $136.74 to $137.73. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $137.75 to $138.36. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1	M Exercise / conversionCommon Stock · Non-derivative	1,890A	72.34	Direct	Form 4 ↗0001782135-26-000028
2026-08-17Filed 2026-08-18	Mercier JohannaOfficer · Chief Comm & Corp Aff Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. F2 Sale prices for the transactions reported range from $136.74 to $137.73. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $137.75 to $138.36. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1	M Exercise / conversionCommon Stock · Non-derivative	23,110A	66.64	Direct	Form 4 ↗0001782135-26-000028
2026-08-17Filed 2026-08-18	Dickinson Andrew DOfficer · Chief Financial Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024. References: F1	S Sale (market/private)Common Stock · Non-derivative	3,000D	138.36	Direct	Form 4 ↗0001310204-26-000024
2026-08-10Filed 2026-08-11	Cain Wettan Keeley MOfficer · EVP Gen Counsel, Legal & Comp Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 The restricted stock units have a three-year vesting schedule. 33.33% vest on each yearly anniversary of the date of grant until fully vested. References: F1, F2	M Exercise / conversionRestricted Stock Unit · Derivative	6,002D	—	Direct	Form 4 ↗0002110603-26-000010
2026-08-10Filed 2026-08-11	Cain Wettan Keeley MOfficer · EVP Gen Counsel, Legal & Comp Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 The restricted stock units have a three-year vesting schedule. 33.33% vest on each yearly anniversary of the date of grant until fully vested. References:	F WithholdingCommon Stock · Non-derivative	2,908D	133.06	Direct	Form 4 ↗0002110603-26-000010
2026-08-10Filed 2026-08-11	Cain Wettan Keeley MOfficer · EVP Gen Counsel, Legal & Comp Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 The restricted stock units have a three-year vesting schedule. 33.33% vest on each yearly anniversary of the date of grant until fully vested. References: F1	M Exercise / conversionCommon Stock · Non-derivative	6,002A	—	Direct	Form 4 ↗0002110603-26-000010
2026-08-03Filed 2026-08-04	O'Day Daniel PatrickDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. F2 Sale prices for the transactions reported range from $129.17 to $130.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $130.18 to $131.17. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $131.21 to $131.47. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. References: F1, F4	S Sale (market/private)Common Stock · Non-derivative	600D	131.3433	Direct	Form 4 ↗0001638643-26-000028

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.